The Royal Pharmaceutical Society’s inclusion and diversity co-ordinator, Amandeep Doll, reveals what the RPS aims to do with its inclusion and diversity strategy over the next five years.
Roger M. Perlmutter: 'The free flow of scientific talent in and out of the UK is incredibly important'Subscription
Roger M. Perlmutter is the executive vice president of Merck Sharp & Dohme, and president of MSD Research Laboratories. On a visit to London, he caught up with Gino Martini, chief scientist at the Royal Pharmaceutical Society, for a chat about the future of pharmaceutical research and his experiences of the industry.
The president of the UK Black Pharmacists Association speaks about the discrimination her members face every day and how pharmacy can tackle it.
Scottish community pharmacy is about to enter a new phase as the Pharmacy First service aims to position it as the first port of call for common clinical conditions.
A principal investigator in one of the UK-based COVID-19 treatment trials speaks about his hopes for the study and the controversy surrounding hydroxychloroquine.
The pharmacy minister on the response to the COVID-19 pandemic, mental health support for pharmacists and what may be the enduring legacy for the sector.
Tony Scully, a publishing director at the Royal Pharmaceutical Society with responsibility for The Pharmaceutical Journal and a portfolio of other editorial products, discusses the evolution of The Pharmaceutical Journal, future plans and how we are supporting pharmacists during the COVID-19 pandemic.
The chief executive officer of the Association of Independent Multiple Pharmacies speaks about how the coronavirus pandemic has affected pharmacy and the risk of impending closures.